PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination
- PMID: 12862433
- DOI: 10.1021/bc020091k
PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination
Abstract
Polymer-directed enzyme prodrug therapy (PDEPT) is a novel two-step antitumor approach that uses a combination of a polymeric prodrug and polymer-enzyme conjugate to generate a cytotoxic drug rapidly and selectively at the tumor site. Previously we have shown that N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-bound cathepsin B can release doxorubicin intratumorally from an HPMA copolymer conjugate PK1. Here we describe for the first time the synthesis and biological characterization of a PDEPT model combination that uses an HPMA-copolymer-methacryloyl-glycine-glycine-cephalosporin-doxorubicin (HPMA-co-MA-GG-C-Dox) as the macromolecular prodrug and an HPMA copolymer conjugate containing the nonmammalian enzyme beta-lactamase (HPMA-co-MA-GG-beta-L) as the activating component. HPMA-co-MA-GG-C-Dox had a molecular weight of approximately 31 600 Da and a C-Dox content of 5.85 wt %. Whereas free beta-L has a molecular weight of 45 kDa, the HPMA-co-MA-GG-beta-L conjugate had a molecular weight in the range of 75-150 kDa, and following purification no free enzyme was detectable. Against the cephalosporin C or HPMA-co-MA-GG-C-Dox substrates, the HPMA-co-MA-GG-beta-L conjugate retained 70% and 80% of its activity, respectively. In vivo (125)I-labeled HPMA-co-MA-GG-beta-L showed prolonged plasma concentration and greater tumor targeting than (125)I-labeled beta-L due to the enhanced permeability and retention (EPR) effect. Moreover, administration of HPMA-co-MA-GG-C-Dox iv to mice bearing sc B16F10 melanoma followed after 5 h by HPMA-co-MA-GG-beta-L led to release of free Dox. The PDEPT combination caused a significant decrease in tumor growth (T/C = 132%) whereas neither free Dox nor HPMA-co-MA-GG-C-Dox alone displayed activity. The PDEPT combination displayed no toxicity at the doses used, so further evaluation of this approach to establish the maximum tolerated dose (MTD) is recommended.
Similar articles
-
PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination.Br J Cancer. 2001 Sep 28;85(7):1070-6. doi: 10.1054/bjoc.2001.2026. Br J Cancer. 2001. PMID: 11592781 Free PMC article.
-
Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.Bioconjug Chem. 2002 Mar-Apr;13(2):206-15. doi: 10.1021/bc010063m. Bioconjug Chem. 2002. PMID: 11906257
-
Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates.Pharm Res. 2002 Apr;19(4):396-402. doi: 10.1023/a:1015170907274. Pharm Res. 2002. PMID: 12033370
-
Two-step polymer- and liposome-enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives.Adv Drug Deliv Rev. 2017 Sep 1;118:52-64. doi: 10.1016/j.addr.2017.09.011. Epub 2017 Sep 12. Adv Drug Deliv Rev. 2017. PMID: 28916497 Review.
-
HPMA copolymer delivery of chemotherapy and photodynamic therapy in ovarian cancer.Adv Exp Med Biol. 2003;519:101-23. doi: 10.1007/0-306-47932-X_7. Adv Exp Med Biol. 2003. PMID: 12675211 Review.
Cited by
-
The expanding role of prodrugs in contemporary drug design and development.Nat Rev Drug Discov. 2018 Aug;17(8):559-587. doi: 10.1038/nrd.2018.46. Epub 2018 Apr 27. Nat Rev Drug Discov. 2018. PMID: 29700501 Review.
-
Stimuli-responsive nanomaterials for biomedical applications.J Am Chem Soc. 2015 Feb 18;137(6):2140-54. doi: 10.1021/ja510147n. Epub 2015 Feb 6. J Am Chem Soc. 2015. PMID: 25474531 Free PMC article.
-
Biotransporting Biocatalytic Reactors toward Therapeutic Nanofactories.Adv Sci (Weinh). 2018 Sep 19;5(11):1800801. doi: 10.1002/advs.201800801. eCollection 2018 Nov. Adv Sci (Weinh). 2018. PMID: 30479925 Free PMC article.
-
Nanomedical engineering: shaping future nanomedicines.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015 Mar-Apr;7(2):169-88. doi: 10.1002/wnan.1315. Epub 2014 Nov 6. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015. PMID: 25377691 Free PMC article. Review.
-
The Prodrug Approach: A Successful Tool for Improving Drug Solubility.Molecules. 2015 Dec 29;21(1):42. doi: 10.3390/molecules21010042. Molecules. 2015. PMID: 26729077 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources